Definitive Contract HHSN261200622012C
- Not listed
- This is a $8,990,511.70 cost-plus-fixed-fee delivery order contract awarded by the National Cancer Institute (NCI) to Westat, Inc., a professional services firm based in Rockville, Maryland. The contract is part of the NCI's Cancer Trials Support Unit (CTSU) Indefinite Delivery/Indefinite Quantity (IDIQ) vehicle, which provides broad-based support for cancer clinical trials. Under this delivery order, Westat will provide administrative and other support services for the CTSU program. The...
- This is a $532,106,035.00 definitive contract awarded by the Department of Health and Human Services National Institutes of Health National Cancer Institute to Westat, Inc., a for-profit professional services firm. The contract, which does not have a set-aside designation, is for the Cancer Trials Support Unit (CTSU) and is a cost-plus-fixed-fee contract type with an August 31, 2006 completion date. Westat has supported various federal agencies through prime and subcontract awards, providing...
- This is a delivery order contract awarded by the National Cancer Institute (NCI), a civilian agency, to Westat, Inc., a prominent for-profit professional services firm. The contract is part of the NCI's Cancer Trials Support Unit (CTSU) program and provides project management and data acquisition support to the NCI's National Clinical Trials Network (NCTN) and Molecular Profiling Center Operations (MCO) organizations and partners. The contract has a ceiling value of $289,624.07 and a period of...
- This is a definitive contract awarded by the National Cancer Institute, a civilian agency within the Department of Health and Human Services, to Westat, Inc., a prominent professional services firm. The contract, titled "INTERDISCIPLINARY STUDIES OF OCCUPATIONAL AND ENVIRONMENTAL CANCER," has a ceiling value of $130,431,971.00 and a completion date of December 31, 2007. It is a cost-plus-fixed-fee contract, meaning the government reimburses the contractor for allowable costs incurred...
- This is a federal contract award to Westat, Inc., a professional services firm, by the National Cancer Institute (NCI), a civilian agency under the Department of Health and Human Services. The $10,071,871.00 cost-plus-fixed-fee contract is for biomedical (applied/exploratory) services and has a completion date of September 29, 2005. The contract is not set aside. Westat has extensive experience providing research, technical assistance, and program support services to various federal agencies,...
- This is a $65,127,025.00 cost-plus-fixed-fee definitive contract awarded by the National Cancer Institute (NCI) to Westat, Inc., a professional services firm. The contract is for clinical genetics branch support services, including services such as site study setup, protocol writing, and electronic patient-reported outcomes collection for cancer clinical trials. Westat has extensive experience providing research, technical assistance, and program support services to federal agencies,...
- This is a cost-plus-fixed-fee delivery order contract awarded by the National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services, to Westat, Inc., a prominent professional services firm. The $32,485,777.00 contract is for infections and immunoepidemiology and integrative tumor epidemiology support services. It has an ultimate completion date of September 19, 2031. The contract is not set aside for any specific business category. Westat holds several...
- This is a definitive contract awarded by the National Cancer Institute (NCI), a civilian agency within the Department of Health and Human Services, to Westat, Inc., a prominent professional services firm. The contract, valued at $21,903,489.00, is for support services related to biostatistical and etiological studies. The contract does not have a set-aside designation. Westat, Inc. has extensive experience working with various federal agencies, providing services such as survey research, data...
- This is a definitive contract awarded by the National Cancer Institute, part of the Department of Health and Human Services, to Westat, Inc., a for-profit professional services firm. The contract, valued at $18,272,174.00, is for developmental and technical services to support the Risk Factor Monitoring and Methods Branch. The contract does not have a set-aside designation. Westat has a history of providing a wide range of services to federal agencies, including survey research, data...
- This federal contract award, valued at $41,827,930.94, was issued by the National Cancer Institute (NCI) to Westat, Inc., a prominent professional services firm based in Rockville, Maryland. The contract, which has no set-aside designation, is for the "DEVELOPMENT AND TECHNICAL SERVICES FOR THE NCI APPLIED RESEARCH PROGRAM" and has an ultimate completion date of August 31, 2014. Westat has extensive experience providing research, technical assistance, and program support services to...
This is a Cost Plus Fixed Fee definitive contract awarded by the National Cancer Institute (NCI), a component of the Department of Health and Human Services, to Westat, Inc., a prominent professional services firm. The contract, with a ceiling value of $2,386,684,477.18, is for the Cancer Trials Support Unit (CTSU), which provides broad-based support for cancer clinical trials. This contract does not have a set-aside designation. Westat has extensive experience working with federal agencies in areas such as public health, education, and transportation, and has held several significant Indefinite Delivery Vehicles (IDVs) with the NCI and other agencies, demonstrating its capacity to provide comprehensive, long-term support for various research and program evaluation initiatives.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| 25 | Other Administrative Action | ($7k) | 3/16/17 | |
| 24 | Change Order | ($866k) | 1/15/15 | |
| 23 | Change Order | ($862) | 4/24/14 | |
| 22 | Other Administrative Action | ($1) | 8/21/13 | |
| 21 | Other Administrative Action | $0 | 5/22/13 |